What is a stock summary page? Click here for an overview.
Business Description
Linical Co Ltd
ISIN : JP3974530002
Description
Linical Co Ltd is a pharmaceutical company.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.8 | |||||
| Equity-to-Asset | 0.43 | |||||
| Debt-to-Equity | 0.35 | |||||
| Debt-to-EBITDA | 3.8 | |||||
| Interest Coverage | 41.15 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.95 | |||||
| Beneish M-Score | -2.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.2 | |||||
| 3-Year EBITDA Growth Rate | 14.5 | |||||
| 3-Year EPS without NRI Growth Rate | -13.8 | |||||
| 3-Year Book Growth Rate | 13 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 11.52 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 1.49 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.43 | |||||
| 9-Day RSI | 55.76 | |||||
| 14-Day RSI | 51.51 | |||||
| 3-1 Month Momentum % | 1.82 | |||||
| 6-1 Month Momentum % | -16.25 | |||||
| 12-1 Month Momentum % | -17.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.56 | |||||
| Quick Ratio | 1.56 | |||||
| Cash Ratio | 0.95 | |||||
| Days Sales Outstanding | 96.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.44 | |||||
| Dividend Payout Ratio | 0.76 | |||||
| 3-Year Dividend Growth Rate | 2.3 | |||||
| Forward Dividend Yield % | 9.17 | |||||
| 5-Year Yield-on-Cost % | 5.38 | |||||
| Shareholder Yield % | 12.71 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.7 | |||||
| Operating Margin % | 5.9 | |||||
| Net Margin % | 2.75 | |||||
| FCF Margin % | 8.39 | |||||
| ROE % | 4.31 | |||||
| ROA % | 1.89 | |||||
| ROIC % | 3.06 | |||||
| 3-Year ROIIC % | -12.73 | |||||
| ROC (Joel Greenblatt) % | 134.05 | |||||
| ROCE % | 6.5 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.56 | |||||
| Forward PE Ratio | 14.38 | |||||
| PE Ratio without NRI | 17.17 | |||||
| PEG Ratio | 21.46 | |||||
| PS Ratio | 0.61 | |||||
| PB Ratio | 1.04 | |||||
| Price-to-Tangible-Book | 1.87 | |||||
| Price-to-Free-Cash-Flow | 7.39 | |||||
| Price-to-Operating-Cash-Flow | 7.16 | |||||
| EV-to-EBIT | 4.43 | |||||
| EV-to-EBITDA | 4.43 | |||||
| EV-to-Revenue | 0.24 | |||||
| EV-to-FCF | 2.84 | |||||
| Price-to-GF-Value | 0.43 | |||||
| Price-to-Projected-FCF | 0.52 | |||||
| Price-to-Median-PS-Value | 0.59 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.77 | |||||
| Price-to-Graham-Number | 1.33 | |||||
| Price-to-Net-Current-Asset-Value | 3.87 | |||||
| Earnings Yield (Greenblatt) % | 22.63 | |||||
| FCF Yield % | 13.53 | |||||
| Forward Rate of Return (Yacktman) % | 10.94 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Linical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 12,307.87 | ||
| EPS (TTM) (円) | 14.975 | ||
| Beta | 0.54 | ||
| 3-Year Sharpe Ratio | -0.66 | ||
| 3-Year Sortino Ratio | -0.95 | ||
| Volatility % | 12.94 | ||
| 14-Day RSI | 51.51 | ||
| 14-Day ATR (円) | 6.807185 | ||
| 20-Day SMA (円) | 333.55 | ||
| 12-1 Month Momentum % | -17.49 | ||
| 52-Week Range (円) | 323 - 463 | ||
| Shares Outstanding (Mil) | 22.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Linical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Linical Co Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Linical Co Ltd Frequently Asked Questions
What is Linical Co Ltd(TSE:2183)'s stock price today?
The current price of TSE:2183 is 円338.00. The 52 week high of TSE:2183 is 円463.00 and 52 week low is 円323.00.
When is next earnings date of Linical Co Ltd(TSE:2183)?
The next earnings date of Linical Co Ltd(TSE:2183) is .
Does Linical Co Ltd(TSE:2183) pay dividends? If so, how much?
The Dividend Yield %  of Linical Co Ltd(TSE:2183) is 4.44% (As of Today), Highest Dividend Payout Ratio of Linical Co Ltd(TSE:2183) was 0.76. The lowest was 0.15. And the median was 0.34. The  Forward Dividend Yield % of Linical Co Ltd(TSE:2183) is 9.17%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers